Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (111-120 of 372) with videos related to

Pageof 38
Sort By:
World Journal of Gastroenterology|March 30, 2013
Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategiesCristina Della Corte, Alessio Aghemo, Massimo Colombo
Gastroenterology|February 6, 2021
Climbing the Everest of Lymph Nodes Staging in Cholangiocarcinoma: Close to the Peak?Luca Aldrighetti, Francesco De Cobelli, Massimo Colombo
International Journal of Molecular Sciences|August 22, 2015
Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C TherapyRoberta D'Ambrosio, Cristina Della Corte, Massimo Colombo
Gastroenterology|March 23, 2020
Clinical and Genetic Markers of Nonalcoholic Fatty Liver Disease and Prediction of Liver Disease Mortality: Ready for Population Screening?Federica Turati, Carlo La Vecchia, Massimo Colombo
Gastroenterology|December 14, 2020
Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?Andrea Casadei-Gardini, Stefano Cascinu, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Impact of HBV therapy on the incidence of hepatocellular carcinomaMichela Triolo, Cristina Della Corte, Massimo Colombo
Gastroenterology|June 27, 2021
Liver Field during Immunotherapy of Hepatocellular Carcinoma: Some Like It HotLuca Valenti, Mario U Mondelli, Massimo Colombo
Nature Reviews. Gastroenterology & Hepatology|July 21, 2010
Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis CAlessio Aghemo, Maria Grazia Rumi, Massimo Colombo
Journal of Viral Hepatitis|March 12, 2008
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?Alessio Aghemo, Maria Grazia Rumi, Massimo Colombo
Hepatology (Baltimore, Md.)|August 5, 2010
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantationCristina Rigamonti, Maria Francesca Donato, Massimo Colombo
Pageof 38

Showing results (111-120 of 372) with videos related to

Sort By:
Pageof 38
World Journal of Gastroenterology|March 30, 2013
Individualized hepatocellular carcinoma risk: the challenges for designing successful chemoprevention strategiesCristina Della Corte, Alessio Aghemo, Massimo Colombo
Gastroenterology|February 6, 2021
Climbing the Everest of Lymph Nodes Staging in Cholangiocarcinoma: Close to the Peak?Luca Aldrighetti, Francesco De Cobelli, Massimo Colombo
International Journal of Molecular Sciences|August 22, 2015
Hepatocellular Carcinoma in Patients with a Sustained Response to Anti-Hepatitis C TherapyRoberta D'Ambrosio, Cristina Della Corte, Massimo Colombo
Gastroenterology|March 23, 2020
Clinical and Genetic Markers of Nonalcoholic Fatty Liver Disease and Prediction of Liver Disease Mortality: Ready for Population Screening?Federica Turati, Carlo La Vecchia, Massimo Colombo
Gastroenterology|December 14, 2020
Atezolizumab and Bevacizumab in Advanced Hepatocellular Carcinoma: Ready for Prime Time?Andrea Casadei-Gardini, Stefano Cascinu, Massimo Colombo
Liver International : Official Journal of the International Association for the Study of the Liver|December 31, 2013
Impact of HBV therapy on the incidence of hepatocellular carcinomaMichela Triolo, Cristina Della Corte, Massimo Colombo
Gastroenterology|June 27, 2021
Liver Field during Immunotherapy of Hepatocellular Carcinoma: Some Like It HotLuca Valenti, Mario U Mondelli, Massimo Colombo
Nature Reviews. Gastroenterology & Hepatology|July 21, 2010
Pegylated interferons alpha2a and alpha2b in the treatment of chronic hepatitis CAlessio Aghemo, Maria Grazia Rumi, Massimo Colombo
Journal of Viral Hepatitis|March 12, 2008
Is a 24 week treatment schedule with PegInterferon and Ribavirin too short for HCV genotype 3 cirrhotics?Alessio Aghemo, Maria Grazia Rumi, Massimo Colombo
Hepatology (Baltimore, Md.)|August 5, 2010
Transient elastography in the early prediction of progressive recurrent hepatitis C following liver transplantationCristina Rigamonti, Maria Francesca Donato, Massimo Colombo
Pageof 38